The search for differences in gene expression that might contribute to PB resistance suggested a role for the ZEB1-RAB25/ESRP1 pathway, which is involved in epithelial-mesenchymal transition (EMT) and is known to affect chemoresistance in breast cancer. Here, ESRP1 is linked to breast cancer.